Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2015

Open Access 01-12-2015 | Research article

An economic evaluation of an augmented cognitive behavioural intervention vs. computerized cognitive training for post-stroke depressive symptoms

Authors: M. van Eeden, J. A. Kootker, S. M. A. A. Evers, C. M. van Heugten, A. C. H. Geurts, G. A. P. G. van Mastrigt

Published in: BMC Neurology | Issue 1/2015

Login to get access

Abstract

Background

Stroke survivors encounter emotional problems in the chronic phase after stroke. Post-stroke depressive symptoms have major impact on health-related quality of life (HRQol) and lead to increased hospitalization and therefore substantial healthcare costs. We present a cost-effectiveness and cost-utility evaluation of a cognitive behavioural therapy augmented with occupational and movement therapy to support patients with a stroke with depressive symptoms in goal-setting and goal attainment (augmented CBT) in comparison with a computerized cognitive training program (CogniPlus) as a control intervention.

Methods

A trial-based economic evaluation was conducted from a societal perspective with a time horizon of 12 months. Stroke patients (aged 18+ years) with signs of depression (Hospital Anxiety and Depression Scale (HADS) – subscale depression > 7) were eligible to participate. Primary outcomes were the HADS and Quality Adjusted Life Years (QALYs) based on the three-level five-dimensional EuroQol (EQ-5D-3 L). Missing data were handled through mean imputation (costs) and multiple imputation (HADS and EuroQol), and costs were bootstrapped. Sensitivity analyses were performed to test robustness of baseline assumptions.

Results

Sixty-one patients were included. The average total societal costs were not significantly different between the control group (€9,998.3) and the augmented CBT group (€8,063.7), with a 95 % confidence interval (−5,284, 1,796). The augmented CBT intervention was less costly and less effective from a societal perspective on the HADS, and less costly and slightly more effective in QALYs, in comparison with the control treatment. The cost-effectiveness and cost-utility analyses provided greater effects and fewer costs for the augmented CBT group, and fewer effects and costs for the HADS. Based on a willingness to pay (WTP) level of €40,000 per QALY, the augmented CBT intervention had a 76 % chance of being cost-effective. Sensitivity analyses showed robustness of results.

Conclusion

The stroke-specific augmented CBT intervention did not show convincing cost-effectiveness results. In addition to other literature, this study provided new insights into the potential cost-effectiveness of an adjusted cognitive behavioural therapy intervention. However, as our study showed a 76 % chance of being cost-effective for one outcome measure (QALY) and did not provide convincing cost-effectiveness results on the HADS we recommend further research in a larger population.
Literature
1.
Jaracz K, Grabowska-Fudala B, Kozubski W. Caregiver burden after stroke: towards a structural model. Neurol Neurochir Pol. 2012;46(3):224–32.PubMed
2.
3.
WHO. World Health Report: Changing History. Geneva, Switzerland: World Health Organization; 2004.
4.
Rasquin SM, Van De Sande P, Praamstra AJ, Van Heugten CM. Cognitive-behavioural intervention for depression after stroke: five single case studies on effects and feasibility. Neuropsychol Rehabil. 2009;19(2):208–22.CrossRefPubMed
5.
Aben I, Verhey F, Strik J, Lousberg R, Lodder J, Honig A. A comparative study into the 1 year cumulative incidence of depression after stroke and myocardial infarction. J Neurol Neurosurg Psychiatry. 2003;74(5):581–5.CrossRefPubMedPubMedCentral
6.
De Wit L, Putman K, Baert I, Lincoln NB, Angst F, Beyens H, et al. Anxiety and depression in the first 6 months after stroke. A longitudinal multicentre study. Disabil Rehabil. 2008;30(24):1858–66.CrossRefPubMed
7.
Gainotti G, Azzoni A, Lanzillotta M, Marra C, Razzano C. Some preliminary findings concerning a new scale for the assessment of depression and related symptoms in stroke patients. Ital J Neurol Sci. 1995;16(7):439–51.CrossRefPubMed
8.
van Mierlo ML, van Heugten CM, Post MWM, Lindeman E, de Kort PLM, Visser-Meily JMA. A longitudinal cohort study on quality of life in stroke patients and their partners: Restore4Stroke Cohort. Int J Stroke. 2014;9(1):148–54.CrossRefPubMed
9.
Wilkinson PR, Wolfe CD, Warburton FG, Rudd AG, Howard RS, Ross-Russell RW, et al. A long-term follow-up of stroke patients. Stroke. 1997;28(3):507–12.CrossRefPubMed
10.
11.
Lincoln NB, Brinkmann N, Cunningham S, Dejaeger E, De Weerdt W, Jenni W, et al. Anxiety and depression after stroke: a 5 year follow-up. Disabil Rehabil. 2013;35(2):140–5.CrossRefPubMed
12.
Rastenyte D, Kranciukaite D. Poststroke depression and its impact on quality of life. Medicina (Kaunas). 2007;43(1):1–9.
13.
Husaini B, Levine R, Sharp L, Cain V, Novotny M, Hull P, et al. Depression increases stroke hospitalization cost: an analysis of 17,010 stroke patients in 2008 by race and gender. Stroke Res Treat. 2013;2013:846732.PubMedPubMedCentral
14.
Struijs JN, van Genugten ML, Evers SM, Ament AJ, Baan CA, van den Bos GA. Future costs of stroke in the Netherlands: the impact of stroke services. Int J Technol Assess Health Care. 2006;22(4):518–24.CrossRefPubMed
15.
van Eeden M, van Heugten CM, Evers SM. The economic impact of stroke in The Netherlands: the euro-Restore4Stroke study. BMC Public Health. 2012;12:122.CrossRefPubMedPubMedCentral
16.
Hackett ML, Anderson CS. Predictors of depression after stroke: a systematic review of observational studies. Stroke. 2005;36(10):2296–301.CrossRefPubMed
17.
Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database Syst Rev. 2008;3:CD003689.PubMed
18.
Broomfield NM, Laidlaw K, Hickabottom E, Murray MF, Pendrey R, Whittick JE, et al. Post-stroke depression: the case for augmented, individually tailored cognitive behavioural therapy. Clin Psychol Psychother. 2011;18(3):202–17.CrossRefPubMed
19.
Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database Syst Rev. 2008;3:CD003689.PubMed
20.
Cuijpers P, Smit F, Bohlmeijer E, Hollon SD, Andersson G. Efficacy of cognitive-behavioural therapy and other psychological treatments for adult depression: meta-analytic study of publication bias. Br J Psychiatry. 2010;196(3):173–8.CrossRefPubMed
21.
Hollinghurst S, Peters TJ, Kaur S, Wiles N, Lewis G, Kessler D. Cost-effectiveness of therapist-delivered online cognitive-behavioural therapy for depression: randomised controlled trial. Br J Psychiatry. 2010;197(4):297–304.CrossRefPubMed
22.
Lamb SE, Hansen Z, Lall R, Castelnuovo E, Withers EJ, Nichols V, et al. Group cognitive behavioural treatment for low-back pain in primary care: a randomised controlled trial and cost-effectiveness analysis. Lancet. 2010;375(9718):916–23.CrossRefPubMed
23.
McCrone P, Ridsdale L, Darbishire L, Seed P. Cost-effectiveness of cognitive behavioural therapy, graded exercise and usual care for patients with chronic fatigue in primary care. Psychol Med. 2004;34(6):991–9.CrossRefPubMed
24.
van der Gaag M, Stant AD, Wolters KJ, Buskens E, Wiersma D. Cognitive-behavioural therapy for persistent and recurrent psychosis in people with schizophrenia-spectrum disorder: cost-effectiveness analysis. Br J Psychiatry. 2011;198(1):59–65. sup 51.CrossRefPubMed
25.
Wiles N, Thomas L, Abel A, Barnes M, Carroll F, Ridgway N, et al. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial. Health Technol Assess. 2014;18(31):1–167. vii-viii.CrossRefPubMedPubMedCentral
26.
Anson K, Ponsford J. Coping and emotional adjustment following traumatic brain injury. J Head Trauma Rehabil. 2006;21(3):248–59.CrossRefPubMed
27.
Anson K, Ponsford J. Evaluation of a coping skills group following traumatic brain injury. Brain Inj. 2006;20(2):167–78.CrossRefPubMed
28.
Bedard M, Felteau M, Mazmanian D, Fedyk K, Klein R, Richardson J, et al. Pilot evaluation of a mindfulness-based intervention to improve quality of life among individuals who sustained traumatic brain injuries. Disabil Rehabil. 2003;25(13):722–31.CrossRefPubMed
29.
Lincoln NB, Flannaghan T, Sutcliffe L, Rother L. Evaluation of cognitive behavioural treatment for depression after stroke: a pilot study. Clin Rehabil. 1997;11(2):114–22.CrossRefPubMed
30.
Nicholl CR, Lincoln NB, Muncaster K, Thomas S. Cognitions and post-stroke depression. Br J Clin Psychol. 2002;41(Pt 3):221–31.CrossRefPubMed
31.
Vickery CD, Sepehri A, Evans CC. Self-esteem in an acute stroke rehabilitation sample: a control group comparison. Clin Rehabil. 2008;22(2):179–87.CrossRefPubMed
32.
de Ridder D, Geenen R, Kuijer R, van Middendorp H. Psychological adjustment to chronic disease. Lancet. 2008;372(9634):246–55.CrossRefPubMed
33.
Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health. 2013;16(2):231–50.CrossRefPubMed
34.
Kootker J, Fasotti L, Rasquin S, van Heugten C, Geurts A. The effectiveness of an augmented cognitive behavioural intervention for post-stroke depression with or without anxiety (PSDA): the Restore4Stroke-PSDA trial. BMC Neurol. 2012;12(1):51.CrossRefPubMedPubMedCentral
35.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.CrossRefPubMed
36.
O’Bryant SE, Humphreys JD, Smith GE, Ivnik RJ, Graff-Radford NR, Petersen RC, et al. Detecting dementia with the mini-mental state examination in highly educated individuals. Arch Neurol. 2008;65(7):963–7.PubMedPubMedCentral
37.
Meyer BC, Hemmen TM, Jackson CM, Lyden PD. Modified National Institutes of Health Stroke Scale for use in stroke clinical trials: prospective reliability and validity. Stroke. 2002;33(5):1261–6.CrossRefPubMed
38.
van Erp J. Relaxation exercises (ontspanningsoefeningen; bodyscan, aandacht voor uw lichaam), De Hart&Vaat groep. 2010.
39.
40.
Spikman JM, Boelen DH, Lamberts KF, Brouwer WH, Fasotti L. Effects of a multifaceted treatment program for executive dysfunction after acquired brain injury on indications of executive functioning in daily life. J Int Neuropsychol Soc. 2010;16(1):118–29.CrossRefPubMed
41.
Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997;27(2):363–70.CrossRefPubMed
42.
Golicki D, Niewada M, Buczek J, Karlinska A, Kobayashi A, Janssen MF, et al. Validity of EQ-5D-5L in stroke. Qual Life Res. 2015;24(4):845–50.CrossRefPubMed
43.
Lamers LM, McDonnell J, Stalmeier PFM, Krabbe PFM, Busschbach JJV. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 2006;15(10):1121–32.CrossRefPubMed
44.
Thorn JC, Coast J, Cohen D, Hollingworth W, Knapp M, Noble SM, et al. Resource-use measurement based on patient recall: issues and challenges for economic evaluation. Appl Health Econ Health Policy. 2013;11(3):155–61.CrossRefPubMed
45.
Noben CY, Evers SM, Nijhuis FJ, de Rijk AE. Quality appraisal of generic self-reported instruments measuring health-related productivity changes: a systematic review. BMC Public Health. 2014;14:115.CrossRefPubMedPubMedCentral
46.
Jonsson B. Ten arguments for a societal perspective in the economic evaluation of medical innovations. Eur J Health Econ. 2009;10(4):357–9.CrossRefPubMed
47.
Oostenbrink JB, Koopmanschap M.A, Rutten F.F.H. Handleiding voor Kostenonderzoek. In. Edited by Adang EMM: Institute for Medical Technology Assessment; 2010: 126.
48.
49.
50.
Hutubessy RC, van Tulder MW, Vondeling H, Bouter LM. Indirect costs of back pain in the Netherlands: a comparison of the human capital method with the friction cost method. Pain. 1999;80(1–2):201–7.CrossRefPubMed
51.
Johannesson M, Karlsson G. The friction cost method: a comment. J Health Econ. 1997;16(2):249–55. discussion 257–249.CrossRefPubMed
52.
53.
Hendriks MRC, Al MJ, Bleijlevens MHC, van Haastregt JCM, Crebolder HFJM, van Eijk JTM, et al. Continuous versus Intermittent Data Collection of Health Care Utilization, Medical Decision Making. 2013.
54.
Sinharay S, Stern HS, Russell D. The use of multiple imputation for the analysis of missing data. Psychol Methods. 2001;6(4):317–29.CrossRefPubMed
55.
van Mastrigt GAPG. Outcome assessment and economic evaluation of short-stay intensive care for coronary artery bypass patients. Maastricht: Maastricht University; 2009.
56.
Knapp M, Thorgrimsen L, Patel A, Spector A, Hallam A, Woods B, et al. Cognitive stimulation therapy for people with dementia: cost-effectiveness analysis. Br J Psychiatry. 2006;188:574–80.CrossRefPubMed
57.
Puhan M, Frey M, Buchi S, Schunemann H. The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2008;6(1):46.CrossRefPubMedPubMedCentral
58.
Raad voor Volksgezondheid en Samenleving (RVS). Zinnige en duurzame zorg. In. Zoetermeer; 2006.
59.
Kind P, Hardman G, Macran S. UK Population Norms for the EQ-5D. Centre for Health Economics: The University of York; 1999.
60.
Wagner M, Melnyk P, Rindress D. Systematic review of guideline recommendations on comparator selection in health economic evaluations. Montreal, Quebec, Canada: BioMedCom Consultants Inc; 2012.
Metadata
Title
An economic evaluation of an augmented cognitive behavioural intervention vs. computerized cognitive training for post-stroke depressive symptoms
Authors
M. van Eeden
J. A. Kootker
S. M. A. A. Evers
C. M. van Heugten
A. C. H. Geurts
G. A. P. G. van Mastrigt
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2015
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-015-0522-y

Other articles of this Issue 1/2015

BMC Neurology 1/2015 Go to the issue

Research article

Education plays a greater role than age in cognitive test performance among participants of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)

Research article

Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany – results from the German AFNET registry

Study protocol

Mitii™ ABI: study protocol of a randomised controlled trial of a web-based multi-modal training program for children and adolescents with an Acquired Brain Injury (ABI)

Research article

Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study

Research article

Cross-cultural adaptation of the stroke action test for Italian- speaking people

Research article

Muscle strength does not explain standing ability in children with bilateral spastic cerebral palsy: a cross sectional descriptive study